Alcidion Group Ltd banner

Alcidion Group Ltd
ASX:ALC

Watchlist Manager
Alcidion Group Ltd Logo
Alcidion Group Ltd
ASX:ALC
Watchlist
Price: 0.11 AUD 4.76% Market Closed
Market Cap: AU$147.7m

P/OCF

25.6
Current
336%
Cheaper
vs 3-y average of -10.9

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
25.6
=
Market Cap
AU$141m
/
Operating Cash Flow
AU$5.8m

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
25.6
=
Market Cap
AU$141m
/
Operating Cash Flow
AU$5.8m

Valuation Scenarios

Alcidion Group Ltd is trading above its 5-year average

If P/OCF returns to its 5-Year Average (22.6), the stock would be worth AU$0.1 (12% downside from current price).

Statistics
Positive Scenarios
0/3
Maximum Downside
-48%
Maximum Upside
No Upside Scenarios
Average Downside
35%
Scenario P/OCF Value Implied Price Upside/Downside
Current Multiple 25.6 AU$0.11
0%
5-Year Average 22.6 AU$0.1
-12%
Industry Average 13.8 AU$0.06
-46%
Country Average 13.2 AU$0.06
-48%

Forward P/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward P/OCF

Peer Comparison

All Multiples
P/OCF
P/E
All Countries
Close
Market Cap P/OCF P/E
AU
Alcidion Group Ltd
ASX:ALC
147.7m AUD 25.6 38.1
JP
Medical Data Vision Co Ltd
TSE:3902
37.9T JPY 81.5 227.5
US
Cerner Corp
LSE:0R00
31.3B USD 18.4 53.1
US
Veeva Systems Inc
NYSE:VEEV
26.4B USD 18.6 29
AU
Pro Medicus Ltd
ASX:PME
14.5B AUD 113.1 61.6
JP
M3 Inc
TSE:2413
1T JPY 15.8 20.5
SE
Sectra AB
STO:SECT B
51.8B SEK 64.7 96.4
US
Waystar Holding Corp
NASDAQ:WAY
4.9B USD 15.4 42.4
US
Doximity Inc
NYSE:DOCS
4.4B USD 14.1 18.6
CN
Winning Health Technology Group Co Ltd
SZSE:300253
19.3B CNY 38.6 -62.7
US
Vocera Communications Inc
F:V00
2.4B EUR 64.1 -328
P/E Multiple
Earnings Growth PEG
AU
Alcidion Group Ltd
ASX:ALC
Average P/E: 65.2
38.1
105%
0.4
JP
Medical Data Vision Co Ltd
TSE:3902
227.5
62%
3.7
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
29
27%
1.1
AU
Pro Medicus Ltd
ASX:PME
61.6
29%
2.1
JP
M3 Inc
TSE:2413
20.5
16%
1.3
SE
Sectra AB
STO:SECT B
96.4
14%
6.9
US
W
Waystar Holding Corp
NASDAQ:WAY
42.4
55%
0.8
US
Doximity Inc
NYSE:DOCS
18.6
15%
1.2
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -62.7
69%
N/A
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -328 N/A N/A

Market Distribution

Higher than 77% of companies in Australia
Percentile
77th
Based on 1 393 companies
77th percentile
25.6
Low
0.2 — 8.9
Typical Range
8.9 — 19.2
High
19.2 —
Distribution Statistics
Australia
Min 0.2
30th Percentile 8.9
Median 13.2
70th Percentile 19.2
Max 8 864.3

Alcidion Group Ltd
Glance View

Market Cap
147.7m AUD
Industry
Health Care

Alcidion Group Ltd. provides intelligent health informatics technology that empowers healthcare professionals with clinical decision support systems to ensure the quality of care for the patients. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-06-24. The company is engaged in development, licensing and reselling its healthcare software products through its strategic partners. The company also delivers product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in Australia, New Zealand and the United Kingdom. The Company’s healthcare software products include Miya, Patientrack, Smartpage and ExtraMed. Miya Precision is a clinical solution based on a FHIR-event platform that facilitates multiple clinical and operational applications. Smartpage is a smartphone and Web-based system for hospital communication and task management provides solution to both clinical and non-clinical users. Patientrack is a solution that supports the capture of that data at the bedside, whether directly entered on a tablet or integrated from patient monitors. Its clinical solutions use digital technology.

ALC Intrinsic Value
0.06 AUD
Overvaluation 45%
Intrinsic Value
Price AU$0.11
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett